Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.800 Biomarker disease GENOMICS_ENGLAND
Entrez Id: 3557
Gene Symbol: IL1RN
IL1RN
0.500 Biomarker disease CTD_human
Entrez Id: 3557
Gene Symbol: IL1RN
IL1RN
0.500 Biomarker disease GENOMICS_ENGLAND
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.400 CausalMutation disease CLINVAR
Entrez Id: 4595
Gene Symbol: MUTYH
MUTYH
0.320 Biomarker disease CTD_human
Entrez Id: 324
Gene Symbol: APC
APC
0.320 Biomarker disease CTD_human
Entrez Id: 843
Gene Symbol: CASP10
CASP10
0.300 Biomarker disease CTD_human
Entrez Id: 3659
Gene Symbol: IRF1
IRF1
0.300 Biomarker disease CTD_human
Entrez Id: 1316
Gene Symbol: KLF6
KLF6
0.300 Biomarker disease CTD_human
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.310 Therapeutic disease CTD_human "Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells." 15723263 2005
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.310 Biomarker disease CTD_human "Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells." 15723263 2005
Entrez Id: 7039
Gene Symbol: TGFA
TGFA
0.300 Therapeutic disease CTD_human "Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells." 15723263 2005
Entrez Id: 374
Gene Symbol: AREG
AREG
0.300 Therapeutic disease CTD_human "Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells." 15723263 2005
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.300 Therapeutic disease CTD_human "Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells." 15723263 2005
Entrez Id: 1839
Gene Symbol: HBEGF
HBEGF
0.300 Therapeutic disease CTD_human "Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells." 15723263 2005
Entrez Id: 374
Gene Symbol: AREG
AREG
0.300 Biomarker disease CTD_human "Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells." 15723263 2005
Entrez Id: 3576
Gene Symbol: CXCL8
CXCL8
0.300 Biomarker disease CTD_human "Gefitinib (""Iressa"", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells." 15723263 2005
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.800 GeneticVariation disease BEFREE 11 patients with confirmed CDH1 mutation who were found to have HDGC in a prophylactic total gastrectomy were collected. 29307626 2018
Entrez Id: 3553
Gene Symbol: IL1B
IL1B
0.300 Biomarker disease CTD_human 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. 19584167 2009
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.800 GeneticVariation disease BEFREE 25-30% of families fulfilling the criteria for hereditary diffuse gastric cancer have germline mutations of the CDH1 (E-cadherin) gene. 20591882 2010
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.800 GeneticVariation disease BEFREE Hereditary diffuse gastric cancer (HDGC) is a familial cancer syndrome caused, in 30-40% of cases, by germline mutations of the E-cadherin/CDH1 gene. 15141383 2004
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.800 GeneticVariation disease BEFREE Hereditary diffuse gastric cancer (HDGC) is defined by germline mutations in the E-cadherin gene, CDH-1. 15753528 2005
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.800 GeneticVariation disease BEFREE Hereditary diffuse gastric cancer (HDGC) is a familial cancer syndrome defined by germline mutation of the E-cadherin gene (CDH-1). 16527687 2006
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.800 GeneticVariation disease BEFREE Hereditary diffuse gastric cancer is a rare autosomal dominant cancer susceptibility syndrome caused by germline E-cadherin (CDH1) mutations in 40% of cases with a high degree of penetrance. 18391748 2008
Entrez Id: 999
Gene Symbol: CDH1
CDH1
0.800 GeneticVariation disease BEFREE Hereditary diffuse gastric cancer (HDGC) is caused by germline E-cadherin (CDH1) mutations in 25-40% of tested families. 18825658 2008